- 一种具有强大的抗癌和抗氧化潜力的植物
Justyna Stefanowicz-Hajduk1, Anna Hering1, Rafał Hałasa2
1Department of Biology and Pharmaceutical Botany, Medical University of Gdańsk, 80-416 Gdańsk, Poland.
Pharmaceuticals (Basel, Switzerland)
|November 27, 2025
概括
芳香 (Coleus aromaticus) 具有强大的抗癌和抗氧化特性,特别是它的乙醇提取物,对胃癌和结肠癌细胞具有显著的活性. 这种天然产品在预防和治疗胃肠道癌症方面表现有前途.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
背景情况:
- 胃肠道癌症 (胃癌,结肠癌) 是一个重大的全球健康挑战,治疗选择有限.
- 天然产品正作为潜在的化学预防药物对抗这些癌症而受到越来越多的关注.
- 以用途而闻名的Coleus aromaticus具有未经检查的生物和药理潜力.
研究的目的:
- 评估各种Coleus aromaticus提取物和果汁的抗癌,抗氧化和抗菌活性.
- 确定植物化学成分,包括总和黄含量,以及挥发性化合物.
- 为了确定胃肠癌化学预防的潜在天然治疗剂.
主要方法:
- 使用MTT测定对人类胃 (AGS) 和结直肠 (HCT 116) 癌细胞进行评估的抗癌活性.
- 通过DPPH,ABTS和降解功率测试评估的抗氧化潜力.
- 使用微稀释确定抗菌活性;植物化学分析包括TPC,TFC,GC-MS和GC-FID.
主要成果:
- 乙醇提取物表现出最强的抗癌活性 (IC50:AGS为4.94μg/mL,HCT为24.99μg/mL) 和抗氧化能力.
- 乙醇和乙醇/水提取物显示出强烈的抗微生物活性对克洛斯特透菌 (MIC <0.02 mg/mL).
- 植物化学分析显示,乙醇提取物中的高 (75.87毫克GAE/g) 和黄 (176.01毫克QE/g) 含量,卡瓦克罗尔是主要的挥发性化合物.
结论:
- 芳香,特别是它的乙醇提取物,显示出作为胃肠道癌症的化学预防剂的显著潜力.
- 该植物强大的抗癌和抗氧化特性,归因于其植物化学特征,需要进一步调查.
- 这项研究支持使用Coleus aromaticus在基于天然产品的癌症预防策略中.
更多相关视频
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
14.2K
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
19.8K
相关概念视频
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
